Investigating Atrial Fibrillation After ICU Discharge
Post Intensive Care Unit Atrial Fibrillation
NA · Centre Hospitalier Universitaire de Besancon · NCT05860894
This study is testing how often atrial fibrillation comes back in adults who had it while in the ICU, using a heart monitor for a year to see how it affects their recovery.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Besancon (other) |
| Locations | 1 site (Besançon) |
| Trial ID | NCT05860894 on ClinicalTrials.gov |
What this trial studies
This study examines the recurrence of atrial fibrillation (AF) in patients who have been discharged from the intensive care unit (ICU). It focuses on adults who experienced new onset AF during their ICU stay and aims to monitor their heart rhythm for up to one year using an implantable ECG Holter device. The research seeks to understand the long-term implications of AF in critically ill patients and the factors that may contribute to its persistence post-ICU. By gathering data on AF recurrence, the study hopes to improve patient outcomes and management strategies.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who experienced new onset atrial fibrillation during their ICU stay.
Not a fit: Patients with a documented history of atrial fibrillation or those admitted to the ICU after cardiothoracic surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better monitoring and management of atrial fibrillation in patients after ICU discharge.
How similar studies have performed: While there is limited data on the long-term persistence of AF post-ICU, similar studies have shown the importance of monitoring heart rhythm in critically ill patients, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18 years * New onset atrial fibrillation diagnosed in the ICU (12 lead ECG or documented episode of atrial fibrillation lasting at least 30 seconds) * Patient hospitalized in the ICU with at least one of the following two criteria: * orotracheal intubation for mechanical ventilation * AND/OR treatment with amines (vasopressors or inotropic agents) * Written informed consent * Patient affiliated to a social security regime (or beneficiary thereof) Exclusion Criteria: * Documented history of atrial fibrillation * patients admitted to the ICU after cardiothoracic surgery * Patients with life expectancy \<12 months * Patients under legal or judicial protection * Patients with no social security coverage * Patients within the exclusion period of another clinical trial
Where this trial is running
Besançon
- Centre Hospitalier Universitaire de Besancon — Besançon, France (RECRUITING)
Study contacts
- Study coordinator: Charles Monnin, MD
- Email: charles.monnin@edu.univ-fcomte.fr
- Phone: 33381668186
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Atrial Fibrillation, Critical Illness, intensive care unit, atrial fibrillation